Author

A. Feber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 4 Organism:human· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Research Focus:gene regulatory network inference· 3 Assay:bulk RNA-seq· 2 Assay:DNA methylation· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Chakravarthy· 2 shared T. R. Fenton· 2 shared A. Al-Ibraheemi· 1 shared A. C. Hirbe· 1 shared A. Chatzipli· 1 shared A. Furness· 1 shared A. Galor· 1 shared A. M. Flanagan· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Chakravarthy

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA

I. Cortes-Ciriano, C. D. Steele, K. G. Piculell, A. Al-Ibraheemi, V. Eulo, M. M. Bui, A. Chatzipli, B. C. Dickson, D. C. Borcherding, A. Feber, A. Galor, J. Hart, K. B. Jones, J. T. Jordan, R. H. Kim, , D. T. Miller

This study identifies genomic patterns in MPNST evolution linked to clinical outcomes and shows these patterns are detectable in cell-free DNA.

bioRxiv · May 3, 2022 · PreprintCancer Biology

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.

A. Chakravarthy, I. Reddin, S. Henderson, C. Dong, N. Kirkwood, M. Jeyakumar, D. Rothschild Rodriguez, N. Gonzalez Martinez, J. McDermott, X. Su, N. Egawa, C. S. Fjeldbo, V. E. Skingen, M. K. Halle, C. Krakstad, , T. R. Fenton

The paper identifies two prognostic cervical squamous cell carcinoma subtypes across three continents, revealing conserved molecular and immune features.

bioRxiv · Apr 2, 2020 · PreprintCancer Biology

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine

T. Rothenburger, K.-M. McLaughlin, T. Herold, C. Schneider, T. Oellerich, F. Rothweiler, A. Feber, T. R. Fenton, M. N. Wass, O. Keppler, M. N. Michaelis, J. Cinatl

This study identifies SAMHD1 as a key regulator of nelarabine response in acute lymphoblastic leukaemias, showing lineage-specific differences in SAMHD1 expression and methylation.

bioRxiv · Dec 3, 2019Pharmacology & Toxicology

Pan-cancer deconvolution of cellular composition identifies molecular correlates of antitumour immunity and checkpoint blockade response

A. Chakravarthy, A. Furness, K. Joshi, E. Ghorani, K. Ford, M. J. Ward, E. V. King, M. Lechner, T. Marafioti, S. Quezada, G. J. Thomas, A. Feber, T. Fenton

This study identifies immune hot and cold tumour subgroups across cancers using DNA methylation-based deconvolution, linking them to immunotherapy response and immune resistance mechanisms.

bioRxiv · Mar 13, 2018Cancer Biology